Jonathan Weiss/ Shuttershock

11 June 2024Big PharmaMarisa Woutersen

Court orders Teva to remove asthma patents from Orange Book

Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers